Name | gsk2200150a |
Synonyms | GSK220150A gsk2200150a 1443138-53-1 1-[(2,3-Dihydro-1,4-benzodioxin-6-yl)methyl]-6',7'-dihydro-spiro[piperidine-4,4'-[4H]thieno[3,2-c]pyran] |
CAS | 1443138-53-1 |
Molecular Formula | C20H23NO3S |
Molar Mass | 357.47 |
Solubility | DMSO : 65 mg/mL (181.83 mM; Need ultrasonic) |
Storage Condition | -20℃ |
In vitro study | GSK2200150A is a novel antimycobacterial agent against Mycobacterium tuberculosis .The activities of GSK2200150A containing the spirocycle core are determined against the virulent M.tuberculosis strain (H37Rv) with MIC of 0.38 μM. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.797 ml | 13.987 ml | 27.974 ml |
5 mM | 0.559 ml | 2.797 ml | 5.595 ml |
10 mM | 0.28 ml | 1.399 ml | 2.797 ml |
5 mM | 0.056 ml | 0.28 ml | 0.559 ml |